Fraud, unreported deaths alleged at Long Island VA

The investigation of the Northport Veterans Affairs Medical Center in Northport, New York, started with unsafe conditions in their operating rooms, but may have uncovered more widespread issues of fraud and abuse.

According to the New York Times, the scrutiny began when it first reported the hospital’s five operating rooms were shut down in February 2016, when “sand-grain-size black particles” began falling from the air ducts.

A congressional investigation dug up a lot more from whistleblowers and internal documents. In an alleged $1 million billing fraud scheme, current and former employees said nurses were told to make cold calls to around 2,000 veterans and then code the calls to make it seem like the patient had called the hospital. One employee compared to it to a private physician calling out of the blue and then billing the insurance company.

The investigation also examined the strange circumstances behind the death of a veteran working at Northport whose body was found on the campus. The autopsy report obtained by the Times said he died from a fentanyl overdose, yet it wasn’t reported to certification agencies or the congressional office, and the hospital’s staff made notes on the patient’s chart as if he were still alive.

“Patient will see me on 5-23. Patient was a no-show. No testosterone will be filled unless he follows us in the clinic,” one clinician wrote in medical records obtained by the Times.

For more on the allegations against the hospital and how its administrators and staff have responded, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.